Difluoromethylornithine Is a Novel Inhibitor of Helicobacter pylori Growth, CagA Translocation, and Interleukin-8 Induction
2011

DFMO Inhibits Helicobacter pylori Growth and Pathogenicity

Sample size: 12 publication 10 minutes Evidence: high

Author Information

Author(s): Barry Daniel P., Asim Mohammad, Leiman David A., de Sablet Thibaut, Singh Kshipra, Casero Robert A. Jr, Chaturvedi Rupesh, Wilson Keith T.

Primary Institution: Vanderbilt University Medical Center

Hypothesis

Does DFMO have direct effects on Helicobacter pylori that contribute to its effectiveness in reducing gastritis and colonization?

Conclusion

DFMO significantly reduces the growth rate of Helicobacter pylori and its pathogenic effects, suggesting it may be a useful addition to anti-H. pylori therapies.

Supporting Evidence

  • DFMO treatment led to a 78% increase in generation time of H. pylori.
  • H. pylori exposed to DFMO showed significant morphological changes.
  • DFMO reduced IL-8 expression in gastric epithelial cells by nearly 50%.
  • Continuous exposure to DFMO was required for its inhibitory effects on H. pylori.
  • DFMO did not affect the growth of other Gram-negative bacteria like E. coli.

Takeaway

DFMO is a substance that can help stop a bacteria called Helicobacter pylori from growing and causing stomach problems.

Methodology

Mice infected with H. pylori were treated with DFMO, and bacterial growth and immune responses were measured.

Limitations

The study primarily used mouse models, which may not fully replicate human responses.

Participant Demographics

Male C57BL/6 mice aged 6–8 weeks were used in the study.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0017510

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication